Roivant Sciences Ltd.

Historical 13F Holders

Symbol
ROIV
CUSIP
G76279101
All holders as of
Q2 2025
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 358 515 M $5.80 B
2025 Q1 331 553 M $5.58 B
2024 Q4 333 562 M $6.65 B
2024 Q3 313 567 M $6.55 B
2024 Q2 314 576 M $6.09 B
2024 Q1 274 604 M $6.36 B
2023 Q4 248 564 M $6.34 B
2023 Q3 219 546 M $6.38 B
2023 Q2 187 498 M $5.02 B
2023 Q1 156 459 M $3.39 B
2022 Q4 118 415 M $3.32 B
2022 Q3 86 371 M $1.19 B
2022 Q2 78 360 M $1.47 B
2022 Q1 57 349 M $1.72 B
2021 Q4 45 339 M $3.42 B